Cancer Research UK logo.
SearchDonate
  • Search

A trial of hormone therapy and abemaciclib for early breast cancer (POETIC A)

Overview

Cancer types:

Breast cancer

Status:

Open

Phase:

Phase 3

Details

This trial is looking at a drug called abemaciclib for women whose hormone therapy might not work so well.

The trial is for women who:

  • have and are due to start treatment

  • who have been through the

Cancer Research UK supports this trial.

Recruitment start: 26 November 2020

Recruitment end: 30 September 2026

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Stephen Johnston

Supported by

Cancer Research UK

Institute of Cancer Research (ICR)

Lilly Oncology

Other information

This is CRUK trial number CRUKE/19/008.

The Institute of Cancer Research have made a short video about the treatment part of the trial (part 2). You can watch it here.(link is external)

Last reviewed: 28 February 2025

CRUK internal database number: 17362

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.